Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3047)	7/22/2010 10:31:20 AM
From: Jibacoa	Respond to of 3722

CBLI opened with an UG and is still up 11.68% on moderate volume of 77Ks, which is already > its ADV bigcharts.marketwatch.com It announced today that the FDA had granted Fast Track status to CBLB502, for the treatment of Acute Radiation Syndrome. CBLI has reported better revenues in the last 4Qs and it also has trimmed its losses in the last 2Qs. The EL for 2010 is around $0.40 vs. $).82 in 2009 and higher losses in 2008 & 2007. For 2011 it is expected to report on the black around $0.15 CBLI has NLTD. The insiders reportedly hold >20% The nearest resistance is from the $3.90 to the $4 level, besides watching whether it may close today's UG. <g> bigcharts.marketwatch.com But from a longer term perspective,the R/R doesn't look bad.<g> ttp://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=cbli&sid=0&o_symb=cbli&freq=2&time=20 Bernard